After finding that circCBFB, derived from CBFB (core-binding factor subunit beta) pre-mRNA, was upregulated in untreated CLL cells from patients, Xia et al. (2018) proposed that it could serve as a prognostic and diagnostic marker in CLL patients. The gene discussed is CBFB; the disease is B-cell chronic lymphocytic leukemia.